Immunohistochemical staining for Myogenin demonstrated positive expression, supporting the diagnosis of high-grade (Grade III) sarcoma with myogenic differentiation. CD68 immunostaining was positive in tumor cells. This evidence concerns the gene MYOG and neoplasm.